About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

GlaxoSmithKline's Rotarix to Be Reviewed

by Ann Samuel on August 15, 2007 at 2:13 PM
Font : A-A+

GlaxoSmithKline's Rotarix to  Be Reviewed

British pharmaceutical group GlaxoSmithKline announced Tuesday that US regulators have agreed to review Rotarix, a vaccine for children to prevent a deadly diarrhoea-inducing bug.

The review process by the US Food and Drug Administration (FDA) is the last hurdle before a possible green light to market the product in the United States.

Advertisement

"GlaxoSmithKline today announced that the US FDA has accepted for review its Biologics License Application for Rotarix, an oral candidate vaccine for infants to prevent rotavirus gastroenteritis," GSK said in a statement.

Rotavirus is a diarrhoea-inducing bug that kills an estimated half a million children a year worldwide.

"This vaccine ... could make a considerable contribution in protecting very young infants from rotavirus disease, a significant burden on families and the healthcare system in the U.S.," added Barbara Howe, vice president of North American Vaccine Development at GlaxoSmithKline.

"We also believe it is important to immunize infants against rotavirus as early as possible."

The Rotarix vaccine has already been licensed in 99 countries around the world, including in the European Union.

Source: AFP
ANN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
World AIDS Day 2021 - End Inequalities, End AIDS
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Iodine Deficiency Disorder 

Recommended Reading
What is diarrhea?
Diarrhea is an important cause of malnutrition, main cause of death in acute diarrhea is due to ......
Iodine Deficiency Disorder
To control IDD, the ‘National Goiter Control Program (NGCP)’ was launched which was later renamed as...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use